Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
108
NMPA:108
Drug Approvals
Composite Potassium Hydrogen Phosphate Injection
- Product Name
- 复合磷酸氢钾注射液
- Approval Number
- 国药准字H20253451
- Approval Date
- Feb 25, 2025
NMPA
Compound Sodium Chloride Injection
- Product Name
- 复方氯化钠注射液
- Approval Number
- 国药准字H20084585
- Approval Date
- Oct 30, 2023
NMPA
Citicoline Sodium Injection
- Product Name
- 胞磷胆碱钠注射液
- Approval Number
- 国药准字H20237048
- Approval Date
- May 4, 2023
NMPA
Ambroxol Hydrochloride Injection
- Product Name
- 盐酸氨溴索注射液
- Approval Number
- 国药准字H20183050
- Approval Date
- Jan 31, 2023
NMPA
Adenosine Cyclophosphate Injection
- Product Name
- 凯济欣
- Approval Number
- 国药准字H20051483
- Approval Date
- Jul 6, 2022
NMPA
Fructose Sodium Diphosphate Injection
- Product Name
- 果糖二磷酸钠注射液
- Approval Number
- 国药准字H20043468
- Approval Date
- Jul 6, 2022
NMPA
Meglumine Adenosine Cyclphosphate and Glucose Injection
- Product Name
- 凯济脉
- Approval Number
- 国药准字H20051484
- Approval Date
- Jul 6, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found